Minimizing the Recurrence Rate in Covid Associated Mucormycosis: Our Experience in 500 Patients

• Published in: Indian journal of otolaryngology, and head, and neck surgery Vol. 76; no. 2; pp. 1898 - 1902
• Main Authors: Jain, Anchal Kumar, Gupta, Yamini, Verma, Jagram, Godha, Surbhi, Prajapati, Indra Prakash
• Format: Journal Article
• Language: English
• Published: New Delhi Springer India 01.04.2024; Springer Nature B.V
• Subjects: Antifungal agents; COVID-19; Fungal infections; Head and Neck Surgery; Medical diagnosis; Medical treatment; Medicine; Medicine & Public Health; Original Article; Otorhinolaryngology; Epidemic; Mucormycosis; Amphotericin B like liposomal amphotericin B; Amphotericin gel; Covid; Immunocompromised; Tablet posaconazole
• ISSN: 2231-3796; 0973-7707
• DOI: 10.1007/s12070-023-04442-5

Mucormycosis is an aggressive, fatal fungal infection. The fungal organisms are ubiquitous and easily affect immunocompromised patients. The main aim of this article is to emphasize over the knowledge of different diagnostic methods (diagnostic nasal endoscopy, ct/ contrast mri pns + orbit + brain, Wet KOH mount), the importance of practising an aggressive surgical resection, medical treatments (liposomal amphotericin B, amphotericin gel, tablet posaconazole, nasal douching, retrorbital amphotericin injection), suction cleaning and regular follow up of the patient after surgical management. This can greatly help in minimizing the recurrence of mucormycosis even in immunocompromised patients in a population. The study performed was a prospective study conducted from April 2021 to July 2021 in which we included 500 patients who presented to the OPD & Department of ENT or Emergency Department of Maharaja Yashwantrao Hospital with complaints suggestive of mucormycosis. The patients who were surgically fit were operated. Out of the 500 patients who were diagnosed with Mucormycosis, from April 2021 to July 2021 complete cure was achieved in 456 patients( 91.2%) and only 44 patients (8.8%) have shown recurrence due to various causes (specially those who did not came for regular follow up). Rhinorbital was the most common site to be involved. In the study it was found that most of the patients which showed recurrence were male, post covid and immunocompromised. Diabetes mellitus was found to be most common among immunocompromised patients. The recurrence in patients with mucormycosis can be minimise by educating the masses regarding importance of public and personal hygiene, and multidisciplinary management with regular follow up offers a better approach to treat this life-threatening condition. The study shows the importance of clinical diagnosis, concurrent surgical treatment, medical treatment, post op care, suction cleaning and regular follow up advice. It is necessary us to take the step forward in this regard, so that in the future we will be better prepared for such type of epidemic.